Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01738100

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Hyeon-Cheol Gwon (from the registry)
Registry
  • NCT NCT01738100
Other papers using this trial's data
  • Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial Journal of the American Heart Association, 2017-04-03 DOI, PubMed 28373244, PMC5533032 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01738100. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
Condition
ST-Segment Elevation Myocardial Infarction
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Morphine Sulfate
Intervention (Drug)
Saline
Lead sponsor
Hyeon-Cheol Gwon (class: other)

Record details

Record id
cardio:ct-nct01738100
Content hash
abe184ca43745e3d55c0358b2d1b133bb476b9c172bdb46fb95da0140de7c614